alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, Neuroscience Research Review.                    

*Date:*                         March 17-18, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites Hotel at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015.                    

*Contact Person:*                         Beata Buzas, PhD, Scientific Review Administrator, National Institute on Alcohol Abuse, and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Rm 3041, Rockville, MD 20852, 301-443-080,                         *bbuzas@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS)

Dated: January 14, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-182  Filed 1-18-08; 8:45 am]

BILLING CODE 4140-01-M
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the

Subcommittee on Dose Reconstruction Review

June 14, 2016

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

10:30 a.m. Eastern Time

Welcome and roll-call

DISCUSSION

1. Case Reviews Issue Resolution for Sets 14-18 (Oak Ridge facilities, 

GDPs, SRS, Hanford, Fernald, Mound, RFP, INL, NTS, and other 

facilities)

5:00 p.m. Adjourn
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Career Enhancement Award for Stem Cell Research (K18).                    

*Date:*                         February 26, 2008.                    

*Time:*                         1 p.m. to 2:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         Yingying Li-Smerin, MD, PhD, Scientific Review Officer, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-7924, 301-435-0277,                         *lismerin@nhlbi.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: January 16, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-278  Filed 1-24-08; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   I, Tammy Skalko, Chief Executive Officer and Chief Financial Officer of Pole Perfect Studios, Inc. (the "Company") certify pursuant to 18 U.P.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:   1. I have reviewed the quarterly report on Form 10-Q of Pole Perfect Studios, Inc. for the Quarter ended September 30, 2009;   2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and   3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the period presented in this quarterly report.  Date: November 12, 2009    /s/ Tammy Skalko Tammy Skalko, Chief Executive Officer Principal Financial and Accounting Officer
EX-10.1



 Exhibit 10.1 

AMENDMENT NO. 1 TO 

EMPLOYMENT AGREEMENT 
 THIS
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (this “Amendment”), dated as of September 23, 2014, is entered into by and among Sterling Bancorp, a Delaware corporation (the “Company”), Sterling National Bank, a
national bank organized under the laws of the United States (the “Bank” and, together with the Company, “Sterling”), and David S. Bagatelle (“Executive”). 

WHEREAS, the Company, the Bank, and Executive have entered into that certain Employment Agreement, dated as of November 1, 2013 (the
“Employment Agreement”); and 
 WHEREAS, the Company, the Bank, and Executive now desire to amend the Employment Agreement
to extend the duration of the Employment Period (as defined in the Employment Agreement). 
 NOW, THEREFORE, in consideration of the mutual
covenants contained herein, the Company, the Bank, and Executive hereby agree as follows: 
  

	1.	Employment. Section 2(a) of the Employment Agreement is hereby amended and restated in its entirety to read as follows: 


Duration. Executive’s period of employment with the Company and the Bank under this Agreement shall begin on the Effective Date and
shall continue until the day following the 3rd anniversary of the Effective Date (or, if a Change in Control occurs prior to such day, the first anniversary of the date of the Change in Control, if later), unless terminated prior thereto by either
Sterling or Executive in accordance with Section 6 hereof (such period of employment being the “Employment Period”). 
  

	2.	Miscellaneous. 

  

	 	(a)	Full Force and Effect. Except as expressly amended by this Amendment, all terms and conditions of the Employment Agreement shall remain in full force and effect. 


 

	 	(b)	Governing Law. This Amendment shall be governed by and construed and enforced in accordance with the laws of the State of New York, without reference to conflicts of law principles, except to the extent governed
by federal law in which case federal law shall govern. 

  

	 	(c)	Counterparts. This Amendment may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.









 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written
above. 
  

			
	STERLING BANCORP
		
	By:	 	 /s/ Jack L. Kopnisky

		 	Name: Jack L. Kopnisky
		 	Title: President and Chief Executive Officer


  

			
	STERLING NATIONAL BANK
		
	By:	 	 /s/ Jack L. Kopnisky

		 	Name: Jack L. Kopnisky
		 	Title: President and Chief Executive Officer


  

	
	EXECUTIVE
	
	/s/ David S. Bagatelle
	David S. Bagatelle


 [Signature Page to Bagatelle Employment Agreement Amendment]
**Exhibit
        32.1**
 
 **Certification**
 **of**
 **Chief
        Executive Officer and Chief Financial Officer**
 
 Pursuant
        to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002, each of the undersigned officers of Webdigs,
        Inc. do
        hereby certify that, to the best of his knowledge:
 
 (a)
        the
        Quarterly Report on Form 10-Q of Webdigs, Inc. for the quarter ended July
        31,
        2008 (the “Report”) fully complies with the requirements of Section 13(a) or
        15(d) of the Securities Exchange Act of 1934; and
 
 (b)
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of Webdigs, Inc.
 
 
 September
                  22, 2008
              /s/
                  Robert A. Buntz, Jr.Robert
                  A. Buntz, Jr.
                *Chief
                  Executive Officer*
  
 September
                  22, 2008
              /s/
                  Edward WickerEdward
                  Wicker
                *Chief
                  Financial Officer*
LYNDAL KENNETH WILKINS

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 1 6

- 0648

_____________________________/

Opinion filed June 1, 2017.

An appeal from the Circuit Court for Santa Rosa C ounty.

John F. Simon , Judge

.

Lyndal Kenneth Wilkins , pro se, Appellant.

Pamela Jo Bondi, Attorney General, and Jennifer J. Moore , Assistant Attorney

General, Tallahassee , for Appellee.

PER CURIAM.

AFFIRMED.

LEWI S, BILBREY , a nd WINOKUR, JJ., CONCUR.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Trade Commission

# FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay, Contact Representative or Renee Hallman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H-303, Washington, DC 20580, (202) 326-3100.

By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 08-361  Filed 1-28-08; 8:45 am]

BILLING CODE 6750-01-M
**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

**PURSUANT TO****18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO SECTION 302 OF**

**THE SARBANES-OXLEY ACT OF 2002**

 

I, Berge Abajian, certify that:

 

1.I have reviewed this Form 10-Q of Bergio International, Inc.; 

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 
|                |                        |
|---------------------|-----------------------------|
| Date: July 17, 2020 | By: */s/ Berge Abajian*     |
|                | Berge Abajian               |
|                | Principal Executive Officer |
|                | Bergio International, Inc.  |
AGENDA 

Advisory Board on Radiation and Worker Health – Meeting 127

Teleconference Meeting

February 27, 2019 

Teleconference Phone: 866-659-0537 

Participant Code: 9933701 

11:00 a.m. (Eastern Time) Start

• Roll-call/Welcome – Mr. Katz, DFO

• Recording December 2018 Meeting Absentee Votes – Mr. Katz, DFO

• Special Exposure Cohort (SEC) Petition Status Update – Mr. Rutherford, DCAS

• Updates from Work Groups and Subcommittees (as necessary) – WG/SC Chairs

• Plans for the April 2019 Board Meeting – All Members

• Board Correspondence

Adjourn
**Exhibit 32.01**

 

**CERTIFICATIONOF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANTTO**

**18U.S.C. SECTION 1350,**

**ASADOPTED PURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

 

I, Ronald C. Martin,certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Oak ValleyBancorp on Form 10-Q for the quarterly period ended March 31, 2009,fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 and that information contained in such Form 10-Qfairly presents, in all material respects, the financial condition and resultsof operations of Oak Valley Bancorp.

 
| Date: May 14, 2009 | By:    | /s/    RONALD  C. MARTIN |
|-------------------------|--------|----------------------------------------------|
|                    | Name:  | **Ronald  C. Martin**                        |
|                    | Title: | **Chief  Executive Officer**                 |

 

I, Richard A. McCarty,certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Oak ValleyBancorp on Form 10-Q for the quarterly period ended March 31, 2009,fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 and that information contained in such Form 10-Qfairly presents, in all material respects, the financial condition and resultsof operations of Oak Valley Bancorp.

 
| Date: May 14, 2009 | By:    | /s/    RICHARD  A. MCCARTY |
|-------------------------|--------|------------------------------------------------|
|                    | Name:  | **Richard  A. McCarty**                        |
|                    | Title: | **Chief  Financial Officer**                   |

 

----
Miller, Diane M.

From:

Sent: Monday, July 01, 2002 4:24 PM

To: NIOCINDOCKET@CDC.GOV

Subject: Comments on proposed rules
NIOSH.doc

Attached, please find my comments on the proposed
rules for Designating Classes of Employees as Members
of the Special Exposure Cohort under EEOICPA.

Thank you for you consideration.

Do You Yahoo!?
Yahoo! - Official partner of 2002 FIFA World Cup
http://fifaworldcup.yahoo.com
ABRWH

Subcommittee on Procedures Review

Action Items and Agenda 

Cincinnati Airport Marriott Hotel

January 5, 2011 

Teleconference: 866-659-0537; Passcode: 9933701 

9:00 a.m. Welcome and Roll-call Katz

9:15 Status report on database improvements since last meeting NIOSH/SCA

 Pre-db review histories; new headings; grouped dates; IGs 

9:45 PER-009 and PER-0012 discussion Lemen/All 

10:30 Break

10:45 Continue PER discussions 

11:00 OTIB-0049-01 and -02 result of tech talk re Pu retained in lung NIOSH/SCA

11:15 OTIB-0054 reply to NIOSH responses SCA

11:45 Review status of TIB-0013 issues All 

12:00 p.m. Overarching issues list and discussion All 

 

12:15 Lunch 

1:30 Status of OTIB 0070 – 15 issues. Priority - Carryover SCA

2:00 Edit four 2-page summaries for Board approval All

3:00 Break

3:15 TIB-0014 review report and verification of cancellation rationale SCA

3:30 RPRT-0044 addition to db and review status SCA

3:45 Report on open items action NIOSH

4:00 Carry-over items

 Status of TIB-0010-08 after NIOSH MCNP runs provided SCA

 Status of revised OTIB-0029-02 response NIOSH 

 OTIB-0021 -02 response to calculation differences & sources SCA 

 -04 response to documentation question SCA 

 Verify OTIB –0051-01 link is complete and item closed NIOSH

 Status of OTIB 0047-02 NIOSH/SCA

 Tracking status of OTIB-0019 All

4:30 Administrative detail and calendar All
<PAGE>





                                                                Exhibit 10.15(a)

February 22, 2002

Mr. Bill Zierolf
President and CEO
CentrPort, Inc.
450 Post Road East
Westport, CT 06880

Re:   Amendment to the Reseller Agreement dated December 22, 2000 between
      Modem Media, Inc. and CentrPort, LLC (the "Reseller Agreement")

Dear Bill:

This letter confirms our agreement to amend the Reseller Agreement as follows:

1.   CentrPort agrees that Modem has no obligation to pay the Unpaid Amount to
     CentrPort and CentrPort waives any and all of its rights that it may have
     to receive the Unpaid Amount.

2.   The term "Revenue" shall include (i) all Revenue recognized by Vendor in
     connection with Vendor's arrangements with Interpublic Group of Companies,
     Inc. ("IPG") or any of IPG's affiliates; and (ii) license fees.

3.   Sections 3(h)(i) and 3(h)(ii) shall be deleted in their entirety and the
     following shall be substituted therefore:

     i.   During 2002, if Vendor recognizes Warrant Revenue equal to $7.5
          million, Vendor will issue Reseller warrants to purchase 587,406
          shares of common stock of Vendor. Vendor will issue Reseller
          additional warrants to purchase 391,604 shares of common stock for
          every incremental $2.5 million of Warrant Revenue achieved above $7.5
          million during 2002. All warrants issued pursuant to Section 3(h)(ii)
          shall be at an exercise price of $.90.

     ii.  During 2003, if Vendor recognizes Warrant Revenue equal to $10
          million, Vendor will issue Reseller warrants to purchase 587,406
          shares of common stock of Vendor. Vendor will issue Reseller
          additional warrants to purchase 391,604 shares of common stock for
          every incremental $2.5 million of Warrant Revenue achieved above $10
          million during 2003. All warrants issued pursuant to Section 3(h)(iii)
          shall be at an exercise price of $.90.

4.   Except as set forth in this letter, all other terms and conditions of the
     Reseller Agreement shall remain in full force and effect.

5.   All capitalized terms shall have their respective meanings as set forth in
     the Reseller Agreement.

Sincerely,

/s/ Marc Particelli
Marc Particelli
President and CEO

AGREED AND ACCEPTED THIS 22nd DAY OF FEBRUARY, 2002 BUT EFFECTIVE AS OF
DECEMBER 22, 2001

CENTRPORT, INC.


      Bill Zierolf                                By: /s/ Bill Zierolf
Date: February 22, 2002
# C_2011206EN.01001001.xml

| 12.7.2011 | EN | Official Journal of the European Union | C 206/10 |
| --- | --- | --- | --- |

12.7.2011

EN

Official Journal of the European Union

C 206/10

---

Euro exchange rates (1)

1

11 July 2011

2011/C 206/05

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4056 |
| JPY | Japanese yen | 113,16 |
| DKK | Danish krone | 7,4584 |
| GBP | Pound sterling | 0,88070 |
| SEK | Swedish krona | 9,1720 |
| CHF | Swiss franc | 1,1715 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,7440 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,180 |
| HUF | Hungarian forint | 266,14 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7091 |
| PLN | Polish zloty | 3,9813 |
| RON | Romanian leu | 4,2298 |
| TRY | Turkish lira | 2,3104 |
| AUD | Australian dollar | 1,3168 |
| CAD | Canadian dollar | 1,3627 |
| HKD | Hong Kong dollar | 10,9425 |
| NZD | New Zealand dollar | 1,6877 |
| SGD | Singapore dollar | 1,7210 |
| KRW | South Korean won | 1 486,46 |
| ZAR | South African rand | 9,5804 |
| CNY | Chinese yuan renminbi | 9,0903 |
| HRK | Croatian kuna | 7,3955 |
| IDR | Indonesian rupiah | 12 001,35 |
| MYR | Malaysian ringgit | 4,2343 |
| PHP | Philippine peso | 60,445 |
| RUB | Russian rouble | 39,6550 |
| THB | Thai baht | 42,618 |
| BRL | Brazilian real | 2,2256 |
| MXN | Mexican peso | 16,4793 |
| INR | Indian rupee | 62,5010 |

Currency

Exchange rate

USD

US dollar

1,4056

JPY

Japanese yen

113,16

DKK

Danish krone

7,4584

GBP

Pound sterling

0,88070

SEK

Swedish krona

9,1720

CHF

Swiss franc

1,1715

ISK

Iceland króna

NOK

Norwegian krone

7,7440

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,180

HUF

Hungarian forint

266,14

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7091

PLN

Polish zloty

3,9813

RON

Romanian leu

4,2298

TRY

Turkish lira

2,3104

AUD

Australian dollar

1,3168

CAD

Canadian dollar

1,3627

HKD

Hong Kong dollar

10,9425

NZD

New Zealand dollar

1,6877

SGD

Singapore dollar

1,7210

KRW

South Korean won

1 486,46

ZAR

South African rand

9,5804

CNY

Chinese yuan renminbi

9,0903

HRK

Croatian kuna

7,3955

IDR

Indonesian rupiah

12 001,35

MYR

Malaysian ringgit

4,2343

PHP

Philippine peso

60,445

RUB

Russian rouble

39,6550

THB

Thai baht

42,618

BRL

Brazilian real

2,2256

MXN

Mexican peso

16,4793

INR

Indian rupee

62,5010

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---